The rise of copyright’s blockbuster initially fueled a boom for pharma, however recent shifts present a complicated outlook for shareholders. Off-patent alternatives are eroding profits, and ongoing litigation add https://kianapqvj892524.bloggerbags.com/46896241/viagra-and-big-pharma-a-volatile-play